Revenue rose 55.3% to KRW 13.1 billion in 2025 from KRW 8.44 billion in 2024. Over the same period the operating loss widened from KRW 12 billion to KRW 15.3 billion, so the operating margin moved from -142.4% to -116.6%. Sales grew faster than the loss, which improved the ratio, but the absolute loss became larger.
The company attributed the widening loss mainly to R&D headcount expansion and R&D investment, with investment in AI model compression technology rising sharply.
Net loss attributable to controlling shareholders narrowed from KRW 24.9 billion in 2024 to KRW 16.6 billion in 2025, and the company has posted losses in both years. Net loss including non-controlling interests was KRW 24.9 billion in 2024 and KRW 16.6 billion in 2025.
Operating cash flow was -KRW 10.8 billion in 2024 and -KRW 11.8 billion in 2025. At end-2025, total equity was KRW 27.5 billion, all of it attributable to controlling shareholders, and total liabilities were KRW 14.8 billion.
On a quarterly basis, fourth-quarter 2025 revenue of KRW 9.5 billion was the largest among the disclosed quarters, then fell 62.3% to KRW 3.58 billion in the first quarter of 2026.
Revenue then rose to KRW 3.82 billion in the second quarter (up 6.7% quarter on quarter) and KRW 4.59 billion in the third quarter (up 19.9%).
Operating losses widened from KRW 2.74 billion in the fourth quarter of 2025 to KRW 4.2 billion in the first quarter of 2026 and KRW 6.19 billion in the second quarter, before narrowing to KRW 3.61 billion in the third quarter.
Net loss attributable to controlling shareholders totaled KRW 16.5 billion over the last four disclosed quarters. Operating expenses for January to September 2026 rose 61.1%, with outsourcing costs roughly doubling and ordinary R&D expenses rising about nineteenfold.
Operating cash outflow for the same nine months was about KRW 8.2 billion, similar to a year earlier. The loss pattern looks more like recurring spending on R&D and outsourcing for business expansion than one-time charges.